Enhancing insight into regional differences: hierarchical linear models in multiregional clinical trials. [PDF]
BMC Med Res MethodolKim J, Kang SH.
europepmc +1 more source
Comments on "A Scale-Free Approach for False Discovery Rate Control in Generalized Linear Models". [PDF]
J Am Stat Assoc, 2023 Li S, Yao Y, Zhang CH.
europepmc +1 more source
Some Dynamical Properties of Non-Linear Baroclinic Waves in a Quasi-Geostrophic Model
, 1979 Shigeo Yoden
openalex +2 more sources
Coefficient Errors Caused by Using the Wrong Covariance Matrix in the General Linear Model [PDF]
, 1974 Otto Neall Strand
openalex +1 more source
Molecular Oncology, EarlyView.Overexpression of CHRDL2 in colon cancer cells makes them more stem‐like and resistant to chemo‐ and radiotherapy. CHRDL2‐high cells have upregulation of the WNT pathway, genes involved in the DNA damage response (DDR) pathway and epithelial‐to‐mesenchymal transition (EMT). This leads to quicker repair of damaged DNA and more cell migration.
Eloise Clarkson, Annabelle Lewis
wiley +1 more source
Evaluating the relative importance of phylogeny and predictors in phylogenetic generalized linear models using the <i>phylolm.hp</i> R package. [PDF]
Plant DiversLai J +5 more
europepmc +1 more source
EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines
Molecular Oncology, EarlyView.The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche +8 more
wiley +1 more source
A new <i>p</i>-value based multiple testing procedure for generalized linear models. [PDF]
Stat ComputRilling J, Tang CY.
europepmc +1 more source
Robust and efficient estimation of nonparametric generalized linear models. [PDF]
Test (Madr), 2023 Kalogridis I, Claeskens G, Van Aelst S.
europepmc +1 more source